Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05510622

Uterine Microbiome in Recurrent Pregnancy Loss

Reproductive Tract Microbiome in Women With Recurrent Pregnancy Loss

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Mỹ Đức Hospital · Academic / Other
Sex
Female
Age
18 Years – 38 Years
Healthy volunteers
Accepted

Summary

The female genital tract microbiome may reflect female reproductive health and may be related to pregnancy outcomes. Disturbances in this microbiome may be associated with adverse reproductive outcomes. The investigators hypothesize that the endometrial and vaginal microbiome composition in women with a history of recurrent pregnancy loss are different, compared with those in normal fertile women.

Detailed description

The investigators want to describe the endometrial microbiome composition in normal fertile women and women with a history of recurrent pregnancy loss by analyzing mid-luteal phase vaginal swab and endometrial biopsy samples using 16S rRNA sequencing.

Conditions

Interventions

TypeNameDescription
OTHERVaginal swab and endometrial biopsyA vaginal swab (DNA/RNA shield collection tube with swab - Zymo Research, CatNo R1107) and endometrial biopsy (Endobrush® - Lab CCD, Paris, France) will be obtained during 18th - 22nd day of the menstrual cycle.

Timeline

Start date
2022-12-12
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2022-08-22
Last updated
2025-09-25

Locations

2 sites across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT05510622. Inclusion in this directory is not an endorsement.